Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marwa A.A. Galal"'
Autor:
Hanan Sayed M. Abozaid, Aya M. Gamal, Ahmed A. Hafez, Ahmed Abdellatif Awad, Yasmine S. Makarem, Marwa A.A. Galal, Gehan Seif Eldein, Abeer M Ghandour, Eman H El-Hakeim, Rania M. Gamal, Fatma H. El-Nouby
Publikováno v:
Reumatología Clínica (English Edition). 18:597-602
Background and objectives The highest incidence of death in systemic sclerosis due to pulmonary disease raises the need for early detection and treatment. The study aim is the assessment of interstitial pulmonary disease by Multi Detector High Resolu
Autor:
Tayseer M. Khedr, Marco Matucci-Cerinic, Doaa M. M. Osman, Safaa A Mahran, Serena Guiducci, Alvaro Garcia Martos, Felice Galluccio, Amira M Elsonbaty, Marwa A.A. Galal, Abdallah El Sayed Allam
Publikováno v:
Lupus Science & Medicine
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
ObjectiveTo evaluate peripheral nerve involvement in patients with SLE with neuromuscular ultrasonography (NMUS) and understand its role in investigating SLE-related peripheral neuropathy.MethodsThis is an observational cross-sectional study on patie
Autor:
Gehan S. Seifeldein, Hosam EldeinGalal Mohamed El-Malah, Marwa A.A. Galal, Doaa Kabil Moussa, Mostafa H. Othman
Publikováno v:
Academic radiology. 27(7)
To evaluate the role of musculoskeletal ultrasound (MSUS) in the grading of rheumatoid arthritis (RA) wrist and hand joints and correlate it with clinical, laboratory, and radiological data.A cross-sectional study recruited 50 patients in a tertiary
Publikováno v:
Reumatologia clinica. 17(3)
Background Systemic sclerosis (SSc) is a rare chronic multi-system autoimmune disease of unknown cause and a complex pathogenesis. The hallmark of the disease is microvascular vasculopathy which results in tissue ischemia with recurrent episodes of r
Publikováno v:
Lupus. 27(5)
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease which affects all aspects of quality of life (QoL) of the patients. Comprehensive patient assessment should include QoL measures in addition to the objective clinical measures of the